Endometrioid carcinoma in pelvic endometriosis in a postmenopausal woman with tamoxifen adjuvant therapy for breast cancer. A case report

M Bardi; E Arnoldi; G Pizzocchero; E Pezzica; D Mattioni; M Perotti

Endometrioid carcinoma in pelvic endometriosis in a postmenopausal woman with tamoxifen adjuvant therapy for breast cancer. A case report

Eur J Gynaecol Oncol. 1994;15(5):393-5.

Authors

M Bardi¹, E Arnoldi, G Pizzocchero, E Pezzica, D Mattioni, M Perotti

Affiliation

¹ Department of Gynecology and Obstetrics, S. Isidoro Hospital Trescore Balneario, Bergamo.

PMID: 7828611

Abstract

This concerns a 57 year old woman operated on in 1988 for a left radical mastectomy due to ductal breast carcinoma and subsequently treated with chemotherapy and Tamoxifen adjuvant. In 1990 a laparo-hystero-oophorectomy was carried out due to uterine fibromas. The woman continued taking Tamoxifen. Two years later a pelvic regeneration appeared, resulting in endometriosis, site of adenomatose hyperplasia and of endometrioid carcinoma GI. This furthermore confirms the importance of a gynecological follow-up for all women treated with Tamoxifen adjuvant therapy.

Publication types

Case Reports

MeSH terms

Breast Neoplasms / drug therapy*
Breast Neoplasms / surgery
Carcinoma, Ductal, Breast / drug therapy*
Carcinoma, Ductal, Breast / surgery
Carcinoma, Endometrioid / etiology*
Carcinoma, Endometrioid / surgery
Chemotherapy, Adjuvant
Endometriosis / etiology*
Endometriosis / surgery
Female
Humans
Hysterectomy
Leiomyoma / etiology*
Leiomyoma / surgery
Middle Aged
Ovarian Neoplasms / etiology*
Ovarian Neoplasms / surgery
Ovariectomy
Tamoxifen / adverse effects*
Tamoxifen / therapeutic use
Uterine Neoplasms / etiology*
Uterine Neoplasms / surgery

Substances

Tamoxifen